APA (7th ed.) Citation

Reinkober, J., Tscheschner, H., Pleger, S. T., Most, P., Katus, H., & Raake, P. (2012). Targeting GRK2 by gene therapy for heart failure: Benefits above β-blockade. Gene therapy, 19(6), . https://doi.org/10.1038/gt.2012.9

Chicago Style (17th ed.) Citation

Reinkober, Julia, Henrike Tscheschner, Sven Torsten Pleger, Patrick Most, Hugo Katus, and Philip Raake. "Targeting GRK2 by Gene Therapy for Heart Failure: Benefits Above β-blockade." Gene Therapy 19, no. 6 (2012). https://doi.org/10.1038/gt.2012.9.

MLA (9th ed.) Citation

Reinkober, Julia, et al. "Targeting GRK2 by Gene Therapy for Heart Failure: Benefits Above β-blockade." Gene Therapy, vol. 19, no. 6, 2012, https://doi.org/10.1038/gt.2012.9.